Stefan Bo Erik Nyman

Biotech-IgG Equity AB engages in the distribution of medical diagnostic and life science products. It offers kits and reagents; assays and reagents for real-time polymerase chain reaction (PCR); PCR instrumentation; clinical microbiology; nuclear instrumentation; radiochemical; automatic liquid handling; and antibodies and proteins. The company was founded in 1996 and is headquartered in Karlstad, Sweden.

Biotech-IgG Equity AB engages in the distribution of medical diagnostic and life science products. It offers kits and reagents; assays and reagents for real-time polymerase chain reaction (PCR); PCR instrumentation; clinical microbiology; nuclear instrumentation; radiochemical; automatic liquid handling; and antibodies and proteins. The company was founded in 1996 and is headquartered in Karlstad, Sweden.

Biotech-IgG Equity AB engages in the distribution of medical diagnostic and life science products. It offers kits and reagents; assays and reagents for real-time polymerase chain reaction (PCR); PCR instrumentation; clinical microbiology; nuclear instrumentation; radiochemical; automatic liquid handling; and antibodies and proteins. The company was founded in 1996 and is headquartered in Karlstad, Sweden.